Format

Send to

Choose Destination
Curr Top Med Chem. 2014;14(3):340-2.

Seeding collaborations to advance kinase science with the GSK Published Kinase Inhibitor Set (PKIS).

Author information

1
Department of Chemical Biology, GlaxoSmithKline, 20 T. W. Alexander Drive, STF 209.3, Research Triangle Park, North Carolina, 27709, USA. william.j.zuercher@gsk.com.

Abstract

To catalyze research on historically untargeted protein kinases, we created the PKIS, an annotated set of 367 small molecule kinase inhibitors. The set has been widely distributed to academic collaborators as an open access tool. It has been used to identify chemical starting points for development of chemical probes for orphan kinases and to investigate kinase signaling in high content phenotypic assays. Access to the set comes with few restrictions other than the requirement that assay results be released into the public domain for the benefit of the entire research community. Examples from the efforts of several collaborators are summarized.

PMID:
24283969
PMCID:
PMC4435035
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Bentham Science Publishers Ltd. Icon for PubMed Central
Loading ...
Support Center